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We estimated the potential bene¢t of reducing rates of
inadequate excision margins in the treatment of lo-
calized invasive melanoma. A computer-simulated
Markov decision analytic model was created to follow
until death a hypothetical cohort of 55 y old Caucasians,
newly diagnosed in a community setting with localized
invasive melanoma.We considered two scenarios: usual
care, and a hypothetical intervention. Markov states in-
cluded well without local recurrence, local recurrence,
cured, and dead. Published population-based data were
used for rates of optimal excision margins, local re-
currence, and mortality. Two outcome measures
were employed: melanoma-related mortality and life
expectancy. Major assumptions included: local recur-
rence occurs within 10 y of diagnosis, and patients
revert to general population mortality rates 10 y follow-
ing melanoma excision or subsequent local recurrence.
For usual care, the model estimated 8.17% melanoma-
related mortality. Modeling intervention with 100%
optimal excision margins reduced this rate to 6.15%, a
25% relative reduction in mortality.This increased aver-
age life expectancy by 0.437 y, which equates to approxi-
mately 11 additional years in the 4% who would not
experience a local recurrence due to improved excision
margins. Increasing the percentage of optimal excision
margins to 80% would still yield substantial improve-
ment, with 6.83% melanoma-related mortality, saving
0.29 life-years compared with baseline. Results were in-
sensitive to moderate changes in the parameter values.
Suboptimal excision margins may account for approxi-
mately one-fourth of all melanoma-related morta-
lity for localized invasive melanoma. If intervention
can achieve even modest adherence to optimal exci-
sion margins, it might substantially reduce mortality.
Key words: decision analysis/Markov model/practice guide-
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M
ore than 53,000 new cases of melanoma were es-
timated to develop in the United States in 2002,
with some 7400 deaths due to melanoma (Jemal
et al, 2002). As melanoma strikes the young as
well as the old, it is also among the most serious
cancers, as measured by years of life lost (Albert et al, 1990); how-
ever, despite the mounting social and economic burden of mela-
noma, mortality from this cancer is preventable due to high cure
rates when the lesion is thin and adequately excised (Weinstock,
2000).
Some studies have reported associations or trends between
higher rates of local melanoma recurrences and narrow excision
margins (Piepkorn and Barnhill, 1996), particularly when margins
are under 1 cm (Milton et al, 1985). Other research has shown that
when melanoma local recurrence arises following surgical exci-
sion, the prognosis is considerably worse (Roses et al, 1983; Urist
et al, 1985; Cruse et al, 1992; Reintgen et al, 1992; Piepkorn and
Barnhill, 1996; Soong et al, 1998). Ng et al (2001), using commu-
nity data from long-term New Zealand Cancer Registry records,
has recently reported higher local recurrence and mortality rates
for suboptimally excised melanoma in a group of patients with
median follow-up of 4.25 y.
This paper extends previous research by projecting long-term
mortality using a Markov decision analytical model. The objec-
tive of this study was to estimate the impact of suboptimal exci-
sion margins in localized invasive melanoma, thereby gauging
the potential bene¢t of a hypothetical intervention to improve
the rates of optimal excision margins.
MATERIALS ANDMETHODS
A Markov decision analytical model was created to follow a hypothetical
cohort of 55 y old white patients with newly diagnosed localized invasive
melanoma from diagnosis of melanoma until death. Our model simulated
two cohorts: standard of care, using community-based data (COM), and a
hypothetical intervention (INT), to reduce the proportion of suboptimal
excision margins.
An overview of the £ow of the model is depicted in Fig 1. Following
diagnosis, the primary melanoma is classi¢ed by Breslow depth. The
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melanoma is subsequently excised. For the COM setting, the probability of
suboptimal excision margin was obtained from community data, whereas
the INTvalues correspond to a hypothetical control group where 80^100%
of lesions are excised optimally.
After these initial events, the patients enter the Markov process as de-
picted in Fig 2. Markov modeling is a form of mathematical modeling that
allows us to simulate lifetime follow-up in a group of patients, thereby
estimating long-term outcomes. This computer simulation allows us to
monitor a hypothetical cohort of patients as their health condition changes
over time. Each distinct health condition is represented in the model by a
health state. During the computer simulation, members of this cohort
move from one health state to another according to a transition probability
that corresponds to the probability of the associated changes in health, as
determined by the literature.The data used to compute transition probabil-
ities of moving from one health state to another for our model is displayed
inTable I. After entering the Markov process (Fig 2), patients in the model
may pass through four possible health states: (i) well without local recur-
rence; (ii) local recurrence; (iii) cured; and (iv) dead. Death can be from
melanoma or other causes. During each annual cycle, patients may remain
in the present health state, or transition to a di¡erent state of health, de-
pending on the transition probability, which is the probability of moving
from one health state to another during that cycle. Eventually all members
of the cohort undergo transition to the dead state, either due to melanoma,
or other causes. When local recurrence occurs in the Markov model, the
patient is at elevated risk for melanoma death for the ¢rst 10 y. Therefore,
the probability of transitioning to death is higher for each cycle during this
period of time.The proportion of patients in a health state at any particular
time is recorded by the model. For our analysis, the outcomes of interest
included melanoma-related mortality rates and number of life-years poten-
tially saved by the hypothetical INT.
Decision model The model used to simulate the computerized cohort
was created with DATATM 3.5 (TreeAge software, Williamstown, MA).
Each melanoma diagnosed was categorized by Breslow depth:o1.00 mm,
1.01^2.00 mm, 2.01^3.00 mm, 3.01^4.00 mm, and44.00 mm. Recurrence
rate following excision, annual mortality following excision, and annual
mortality following local recurrence, varied by Breslow depth. Minimum
excision margins for each Breslow depth were based on recommendations
by Ng et al (2001) who used regression to determine excision margins
with minimal recurrence rates. These recommendations are consistent
with American Academy of Dermatology recommendations, with the
exception of slightly wider margins (1.5 cm rather than 1 cm) for
melanoma between 1 and 2 mm Breslow depth. Excision margins less
than the recommendation was considered suboptimal for purposes of
classi¢cation. Following optimal or suboptimal margin excision of the
melanoma, Ng et al (2001), data were used to model the probability of
Figure1. Decision £owchart. Flow chart depicting the overall £ow of
the model.
Figure 2. Markov process. Markov simulation of hypothetical cohort of
patients over time through a series of distinct health states until death. Pa-
tients enter the Markov process following excision of the primary melano-
ma. After entering the Markov process, each patient has a certain
probability of experiencing a number of events, corresponding to the
health-related Markov States described in the boxes above. Each patient
begins in the ‘‘Well without local recurrence’’ box, and has an annual risk
of dying from melanoma or other causes, living without recurrence (stay-
ing in the box), or recurring locally for up to the ¢rst 10 y following diag-
nosis. Arrows designate possible transitions during each annual cycle. The
Markov computerized simulation follows a hypothetical cohort of patients
as they continuously cycle between Markov States until, eventually, they
settle into the death state. nDeath from other causes is possible at any time
in the model, but is not depicted in this ¢gure.
Table I. Melanoma mortality and local recurrence by Breslow
Breslow depths
p1.00 mm (%) 1.01^2.00 mm (%) 2.01^3.00 mm (%) 3.01^4.00 mm (%) 44.00 mm (%)
2 y mortality for local recurrencea 11.0 22.7 26.7 26.2 34.5
5 y mortality for local recurrencea 31.7 39.9 50.1 57.3 56.6
10 y mortality for local recurrencea 55.8 58.0 70.3 77.4 74.9
SEER 10 y relative survival 1988^98b 98.6 83.9 68.0 57.2d 57.2d
SEER Breslow depth distribution 1995^98b,c 74.0 16.0 4.8 2.0 3.3
Local recurrence rate for optimal excision, lifetime 0.0 1.2 2.2 3.6 5.1
Local recurrence rate for suboptimal excision, lifetime 4.7 8.0 28.0 35.5 17.9
aDong et al (2000).
bGenerated by SEER-Stat Software. Additional restrictions include no in situ melanoma. Localized by ‘Book 6 SEER sum staging guide’ white ages 45^64 (average
about age 55).
cValues do not add to one due to rounding error.
dBreslow depth categories 3^4 and44 were collapsed to ensure robust estimates.
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local melanoma recurrence, varying according to optimal and suboptimal
margin status, and mortality data from Dong et al (2000), was used to
obtain mortality given local recurrence. The de¢nition for local
recurrence was consistent across data sources used, and de¢ned as
recurrence within 5 cm of (or within) the surgical scar (Dong et al, 2000;
Ng et al, 2001).
Data sources In the baseline analysis, we assumed 100% optimal
excision margins for INT in order to estimate the maximum potential
bene¢t of reducing the rate of suboptimal excision margins. In sensitivity
analysis, we examined varying success rates for the intervention.
Randomized trial data comparing melanoma excision margins has so far
been limited in power, and have not yet examined the full range of
excision margins for the spectrum of Breslow depths seen in community
practice. For this reason we have utilized the best sources of observational
data, using sensitivity analysis to test the impact of potential inaccuracy in
the data on model conclusions.
Data from Ng et al (2001), based on the New Zealand Cancer Registry,
was employed to establish the proportion of optimal excision margins for
each Breslow depth, and corresponding local recurrence rates. This was the
study best suited to answer our question because it had a population-based
cohort with large sample size (n¼1591), and reported the full range of
excision margins performed in the community practice for each 1 mm
Breslow depth increment of lesion. Ng et al’s paper also was contemporary
and provided estimates of these rates in 1mm increments of Breslow depth,
the most highly predictive indicator of localized melanoma prognosis.
Stratifying by Breslow depth adjusts for a large potential bias. While
observational in design, Ng et al’s paper provided the most detailed
information about the wide spectrum of excision margins and local
recurrence arising in the general community with patients treated by
various physicians in public and private settings. Thus, this source
permitted gauging the impact a modest intervention could have on such a
generalizable real-world setting.
Local recurrence mortality rates for up to 10 y after diagnosis were
derived from Dong et al (2000), the largest systematic study of long-term
local melanoma recurrence mediated mortality to our knowledge (n¼ 648
local recurrences taken from a 10,500 patient registry).Where the Ng paper
have some data on mortality, these data were not su⁄ciently detailed to be
incorporated into the model. Dong et al (2000), report a substantially
longer time period with 2, 5, and 10 y mortality broken down by age and
year of follow-up compared with the Ng et al (2001) paper which reported
a median follow-up of 51 mo, with no break down by follow-up time.
Finally, the Dong et al (2000) data were particularly well-suited to be
combined with the Ng data in the model, because they have identical
de¢nitions of local recurrence: within 5 cm of (or within) the surgical
scar. The long follow-up period enabled estimation of long-term
mortality estimates strati¢ed by Breslow depth of the initial lesion. The
mortality rates for each Breslow depth reported by Dong et al (2000),
were interpolated to ¢t the Breslow depth categories used by Ng et al
(2001), (o1 mm, 1.01^2.00 mm, 2.01^3.00 mm, 3.01^4.00 mm, and44
mm). Cumulative mortality rates for di¡erent time periods were
transformed into annual mortality rates using standard survival curves.
Dong et al (2000), data were also used to derive the distribution of local
recurrences over time. The overall rates of local recurrence were obtained
from Ng et al for each Breslow depth.
Relative mortality rates for melanoma came from the Surveillance,
Epidemiology, and End Result (SEER) registry of the National Cancer
Institute (NCI), 1988^1998, using the SEER-Stat software utility. SEER
was selected as the best source of robust population-based mortality data
because it is widely regarded as the gold standard source of cancer
mortality data in the United States, with date of death validated from
multiple sources (Ries et al, 2003).
SEER rates were strati¢ed by Breslow depth but cannot be strati¢ed
according to who had local recurrence. Although there were no data for
the annual mortality rates in the absence of local recurrence, these
probabilities were obtained using the model itself, by determining the
rate that resulted in an overall mortality rate matching the SEER data. To
simulate the present trend towards thinner melanomas (MacKie et al, 1997;
Dennis, 1999; Garbe et al, 2000), only the most recent data from Seer Cancer
Statistics Review, 1973^1997 (2000) were used to estimate the distribution of
melanoma thickness. Parameter values obtained from these sources to
determine the model Markov transition probabilities are summarized in
Table I. Other cause mortality was obtained from life tables from U.S.
Vital Statistics.
Model assumptions Several simplifying assumptions were made in
modeling the decision analysis. These include: (i) local recurrence occurs
within 10 y; (ii) mortality rates revert to those of the general population
10 y following diagnosis or local recurrence; and (iii) local recurrence
occurs within 5 cm of the surgical scar.
Sensitivity analysis Sensitivity analyses were conducted for all
parameters in order to gauge the impact of unknown biases in the
estimates obtained from the literature on model conclusions. Twenty-¢ve
percent changes in parameter values were selected to test the robustness of
the model against biases of moderate size. As it is recognized that
communities may vary greatly with respect to percent optimal excision
margins particularly wide ranges (50% relative change) were used for
sensitivity analysis on the proportion of suboptimally excised melanoma
in the general community.
RESULTS
Table II summarizes the results from the baseline analysis of the
Markov model for the simulated cohort. Based on community
data, with the present community Breslow depth distribution ta-
ken from SEER, our model estimates 8.17% melanoma-related
mortality following localized melanoma. Modeling a hypotheti-
cal intervention (INT), with 100% optimal excision margins,
predicted reduced mortality in this patient group by some 25%,
to 6.15% melanoma-related death, with local recurrence rates
dropping from 4.59% to 0.53%. This survival bene¢t corre-
sponds to an estimated average increase in life expectancy of
0.437 life-years per patient. Because the SEER Breslow depth dis-
tribution is predominantly thin melanoma, accounting for an
overall relatively low mortality rate,Table II also displays a strati-
¢ed analysis of both outcome measures by Breslow depth levels.
Whereas patients with the thinnest melanomas were predicted to
Table II. Results. Local recurrence, mortality, and life expectancy outcomes
Outcome measure
INT rate of optimal excision margins
Community (100%) 80% 60%
Proportion with local recurrence (%) 4.59 0.53 1.89 3.26
Melanoma-related mortality (%) 8.17 6.15 6.83 7.51
p1.01 1.77 0.42 0.90 1.39
1.01^2.00 17.99 16.03 16.63 17.22
2.01^3.00 34.16 26.66 29.20 31.74
3.01^4.00 48.25 37.84 41.09 44.35
44.00 42.80 38.49 39.74 41.01
Life expectancy (y) 25.22 25.65 25.51 25.36
p1.01 26.74 27.03 26.92 26.82
1.01^2.00 2.93 23.36 23.23 23.10
2.01^3.00 19.06 20.68 20.13 19.58
3.01^4.00 15.63 17.88 17.17 16.47
44.00 16.78 17.73 17.45 17.17
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have the greatest proportional decrease in mortality (a 76.27% re-
lative reduction, from 1.77% to 0.42%), patients with relatively
thick melanoma (3^4 mm category) had the greatest reduction
in absolute mortality, with mortality decreasing by 10.41%, from
48.25% to 37.84%.
Allowing for 25% change in rates of mortality and local recur-
rence above and below the baseline values reported in the studies
had little impact on the results. Sensitivity analysis on melanoma-
related mortality estimates in patients without local recurrence
yielded a range from 0.41 to 0.47 life-years saved, with a 1.9^
2.1% reduction in mortality through INT. Sensitivity analysis
on the rates of local recurrence resulted in 0.33^0.54 life-years
saved, with a 1.5^2.5% reduction in mortality. Sensitivity analysis
on mortality following local recurrence yielded 0.34^0.51 life-
years saved with a 1.6^2.3% reduction in mortality.
As we can see in Table II, if INT increased the percentage of
optimal excision margins to only 80%, it would still yield a sub-
stantial improvement in outcomes over current community op-
timality with a 6.83% melanoma-related mortality rate, saving an
average of 0.29 life-years per patient compared with baseline.
Community baseline optimality reported by Ng et al (2001) aver-
aged 38.2% with values ranging from 30.6% to 42.6% for the
di¡erent Breslow depths. AsTable II illustrates, even if commu-
nity rates of optimality are already as high as 60%, which is
about 50% higher than reported by Ng et al (2001), we would still
expect substantial bene¢t by raising optimality to 80%, saving an
average of 0.147 life-years per patient, and reducing mortality by
0.68%.
Model validation The model was run for 10 y to calculate the
melanoma-related mortality rate of local recurrence, strati¢ed by
Breslow depth. The rates generated matched the SEER and Ng
et al (2001), data. Although this was by design, the validation
procedure provided a means of checking for programming errors.
DISCUSSION
It has long been speculated that excision margins could a¡ect
mortality, but only recently has there been evidence to support
this. Our analysis suggests that suboptimal excision margins may
have substantial impact on long-term outcomes, and that an in-
tervention improving the rate of optimal excision margins could
potentially result in a real reduction in melanoma mortality of
2%, or a relative reduction of nearly 25%. In practice, adherence
to clinical guidelines such as performing excision margins may be
less than complete (Haynes and Haines, 1998; Cranney et al, 2001).
Multidisciplinary Melanoma Program, a co-ordinated and multi-
disciplinary approach to the management and treatment of mela-
noma patients, is one possible means to increase optimal excision
margin rates. Multidisciplinary Melanoma Program has been
identi¢ed in the literature with closer adherence to evidence-
based guidelines through enhanced multi-specialty communica-
tion and co-ordination of activities (Fader et al, 1998; Johnson et al,
2000). Such Multidisciplinary Melanoma Program case manage-
ment may involve reviewing slides to verify recorded Breslow
depths, and making appropriate recommendations based on these
readings. Other advantages of specialized and multidisciplinary
cancer care have been reported elsewhere (Selby et al, 1996;
Chang, 1998; Parry et al, 1999).
The observed reduction in mortality with improved excision
margins is consistent with the ¢ndings of Ng et al (2001), who
observed local recurrence rates of 11.4% for suboptimal, as op-
posed to just 1.1% for optimally excised melanomas. This reduc-
tion in mortality due to optimal excision margins results from
the reduction in local recurrence, which carries 10 y mortality
ranging from 56% to 75%, depending on Breslow depth. For
the distribution of Breslow depths taken from SEER (Seer Can-
cer Statistics Review, 2000), which has a thinner melanoma dis-
tribution than found in the older data set of Ng et al, the model
estimated local recurrence rates for the community and INT set-
ting were 4.59% and 0.53%.
The di¡erence in mortality between optimal and suboptimal
groups, amounting to an average saving of 0.437 life-years per
patient, is misleading because the potential bene¢t of 100% opti-
mal excision margins is distributed only among the patients for
whom local recurrence would be averted. Thus, for 96% of pa-
tients there would be no bene¢t in life expectancy, but the other
4% would gain an average of 10.76 life-years. Because melanoma
a¡ects young adults as well as old, the potential impact of redu-
cing such preventable melanoma-related mortality is particularly
signi¢cant for society.
In the past, an arbitrarily wide surgical excision margin has
contributed to preventable morbidity, cosmetic harm, psychoso-
cial distress, and expense of additional health services (Cassileth
et al, 1983; Day and Lew, 1983; O’Rourke and Altmann, 1983). Sur-
gical margins have since appropriately narrowed. In recent years,
however, some have voiced a concern that more narrow excision
margins for melanoma are in vogue, we may be moving to ex-
cessively conservative excision margins before they have been
clearly established as safe. Data from the American Academy of
Dermatology have indicated that, although there has been an ap-
propriate decrease in subjectively wide excision margins (greater
than 2 cm) for melanoma, the percentage of inappropriately nar-
row excision margins has concurrently increased (Johnson and
Sondak, 1995; Salopek et al, 1995). The concern for inadequate ex-
cision of melanoma is even greater for the primary care practice
setting, where melanoma is more often inadequately or incom-
pletely excised (McWilliam et al, 1991; Herd et al, 1992; Corwin
et al, 1997; Khorshid et al, 1998).
Whereas we have employed the results of Ng et al (2001), who
found increased local recurrence and mortality with suboptimal
excision margins, previous studies comparing excision margins
greater than 1 cm have often failed to ¢nd such survival di¡er-
ences (Piepkorn and Barnhill 1996). Most of these studies lacked
the power and long-term follow-up necessary to detect a 2%
mortality di¡erence in excision margin groups. Inadequately
controlled observational studies that failed to show a di¡erence
were also susceptible to selection bias that can mask a true di¡er-
ence, as physicians are expected preferentially to perform wider
excisions on melanomas with a less favorable prognosis (Bagley
et al, 1981). Recent randomized controlled trials, comparing two
variably optimal excision margin groups, both at least 2 cm in
width have, not surprisingly, failed to demonstrate survival di¡er-
ences (Balch et al, 1993; Karakousis et al, 1996; Ringborg et al, 1996;
Cohn-Cedermark et al, 2000). The long running World Health
Organization (WHO) randomized trial examining local melano-
ma excision margins and mortality has failed to detect statisti-
cally signi¢cant survival di¡erences comparing 1 cm vs 3 cm
margin groups of thin melanoma, yet observed all four local re-
currences in the conservatively excised 1^2 mm Breslow depth
group (Veronesi and Cascinelli, 1991;Weinstock, 1997). Moreover,
in our power analysis of a recent follow-up study based on the
WHO trial cohort (Cascinelli, 1998) we have found that 254
patients in the 1.1^2.0 mm Breslow group in the WHO trial is
far short of the 3324 patients per randomized controlled trial
group necessary to detect the 2.6% mortality di¡erence our
model predicts for a group of patients with the same distribution
of lesion Breslow depths as this trial (Rosner, 2000). Unfortu-
nately, there are no randomized controlled trials of su⁄cient size
to detect this predicted mortality di¡erence. This WHO also
found that patients with narrow excision margins have increased
local recurrence rates (2.6% vs 0.1%), but due to small sample
sizes was unable to ¢nd statistical signi¢cance (Cascinelli, 1998).
Signi¢cant preventable melanoma mortality suggested by this
study underscores the importance of follow-up prospective
studies with adequate power and appropriate adjustment of
prognostic indicators to detect clinically signi¢cant di¡erences
in mortality as well as in local recurrences. Such studies are
needed to determine the extent to which local recurrence
mediates mortality.
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It has been argued in the literature that equivocal results with
respect to mortality despite observed di¡erences in recurrence
rates may be explained by local metastasis over which wider sur-
gical margins would make no prognostic di¡erence (Piepkorn
and Barnhill 1996; Piepkorn, 1998); however, the theory that
local metastasis is responsible for all surplus local recurrences in
suboptimally excised lesions is inconsistent with Ng et al (2001),
which did ¢nd increased mortality as well as increased local re-
currence for suboptimally excised lesions of the same Breslow
depth.
Noteworthy is the low rate of optimal excision margin re-
ported by Ng et al (2001) that was used in this study (38.2%).
Whereas this ¢gure seems small, Ng et al’s data covered a span of
time when large expansive margins were more in vogue than to-
day, suggesting these values may actually be an underestimate of
contemporary practice. As previously described, sensitivity analy-
sis based on an increase by half in optimal excision margins sug-
gest signi¢cant mortality could be averted by an intervention
even if these ¢gures were signi¢cantly underestimated.
Our model has several important strengths. Relative melano-
ma mortality rates from SEERwere utilized to prevent bias by
other cause mortality that can in£ate mortality ¢gures for older
patients, and complicate comparisons across studies. We used
community-based data, which is more representative of actual ex-
perience in these settings. Our model was restricted to invasive
localized melanoma, with all estimates strati¢ed into 1 mm
Breslow depth increments to account and control for variation
in prognosis.
Markov modeling and decision analysis are powerful tools for
estimating potential impact of clinical decision making and other
simulations (Sonnenberg and Beck 1993) that have been underu-
tilized in dermatology. Markov modeling has been particularly
useful in simulating the progression of melanoma. Wanek et al
(1993), used multistage Markov methods to shed light on melano-
ma progression over time, and the contribution of di¡erent risk
factors to its progression.The Markovian approach in this analysis
permitted melanoma progression to be captured more accurately
than in previous models, because the course of disease was seen to
pass through multiple discrete clinical stages. In another report,
Dabrowska et al (1998), combined a multistate Markov chain pro-
cess with Cox proportional hazards regression.The Markov chain
methodology facilitated detailed exploration of interactions
among prognostic factors for melanoma progression.
In this study, the Markov approach permitted long-term fol-
low-up of our patients, sensitivity analysis to be performed to test
the robustness of the model conclusions to reasonable deviations
in assumptions and model parameters, as well as simulating the
implications of di¡erent degrees of e¡ectiveness for INT in terms
of optimal melanoma excision rates. Incorporating data from
multiple sources in the form of a model also permitted us to in-
vestigate a question no single study had the necessary power and
length of follow-up to address. Because it is possible in practice
for clinicians to perform wider excision margins on lesions with
worse prognosis (for reasons besides Breslow depth, which was
accounted for), the observed bene¢t of performing optimal exci-
sion margins may have been underestimated by Ng et al (2001).
This potential bias suggests that the model may underestimate
the bene¢t of performing optimal excision margins.
Our model estimates that inadequate local excision of melano-
ma may be responsible for up to one-fourth of localized melano-
ma-related mortality. Even 80% adherence to optimal excision
margins would preserve half the bene¢t in reduction in melano-
ma-related mortality. An intervention capable of improving ad-
herence to recommended excision margin for corresponding
depth of melanoma may signi¢cantly reduce melanoma-related
mortality in patients with localized melanoma. Future work
should explore the cost-e¡ectiveness of such interventions. Our
model suggests substantial mortality could be prevented by more
closely adhering to excision margin recommendations, but does
not incorporate cost or quality of life data also pertinent to clin-
ical guidelines and policy.Whereas there is a need for further data
to corroborate these model-generated estimates, the results here
are provocative and provide motivation for further study.
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